Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Enhancement of somatostatin-receptor-targeted 177Lu-[DOTA0-Tyr3]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation, Nuclear Medicine and Biology, August 2008, Elsevier,
DOI: 10.1016/j.nucmedbio.2008.05.003.
You can read the full text:
Contributors
The following have contributed to this page
